Trial Profile
Laboratory measurement of direct oral anticoagulants on patients with atrial fibrillation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 22 Jun 2017 New trial record